The FDA announced it has approved fezolinetant for the treatment of moderate to severe hot flashes due to menopause. Fezolinetant (Veozah, Astellas Pharma) is an oral medication. It is the first neurokinin 3 receptor antagonist approved by the FDA for treatment of moderate to severe vasomotor symptoms, according to an FDA press release. This medication is not a hormone; fezolinetant binds
FDA green lights a new type of drug for menopausal hot flashes ktvz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ktvz.com Daily Mail and Mail on Sunday newspapers.
FDA approves first-of-its-kind drug to treat hot flashes go.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from go.com Daily Mail and Mail on Sunday newspapers.